A practical reference on analytical methods: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-05-15. Anything still debated is marked as such rather than presented as settled.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Major agencies have not authorized it for therapeutic use. |
| Anti-doping status | Prohibited in sport | Listed among peptide hormones and related substances. |
| Primary research area | Metabolic and body-composition effects | Studies often examine fat mass or lipid markers. |
| Human evidence | Limited and mixed | Public data do not establish clinical efficacy. |
| Analytical detection | LC-MS and immunoassays | Methods vary in sensitivity and validation. |
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Maximinus Thrax, Roman emperor (c. 173, reigned 235–238). Descriptions, as well as depictions, indicate acromegaly, though remains of his body are yet to be found. Lorenzo de' Medici (1449–1492) may have had acromegaly. Historical documents and portraits, as well as a later analysis of his skeleton, support the speculation. Sergei Rachmaninoff (1873–1943), pianist and composer, who was noted for his hands that could comfortably stretch a thirteenth on the piano. He was not diagnosed with acromegaly in his lifetime, but a medical article from 2006 suggests that he might have had it. Adam Rainer (22 February 1899 – 4 March 1950), Austrian man who is the only person in recorded history to have been both a dwarf and a giant. He is believed to have had acromegaly.[51]
Indolyl-3-acryloylglycine, also known as trans-indolyl-3-acryloylglycine, or IAG for short, is a compound consisting of an indole group attached to an acrylic acid moiety, which is in turn attached to a glycine molecule. This compound has been shown to isomerize when exposed to light. It is likely a metabolic intermediate in the biosynthesis of tryptophan, and is synthesized from tryptophan via indolepropionic acid and indoleacrylicacid (IAcrA). It is also likely that IAcrA is converted into IAG in the gut wall. It may also be produced by certain elements of the mammalian gut microbiota by phenylalanine ammonia-lyase. Identifiable in the urine by high-performance liquid chromatography, it may be a biomarker for autism spectrum disorders, as demonstrated by the research of Paul Shattock and other researchers from Australia. These researchers have reported that urinary levels of IAG are much higher in autistic children than in controls; however, other researchers have found no association between IAG concentrations in the urine and autism. Its excretion in the urine may also be changed in Hartnup disease and celiac disease, as well as photodermatosis, muscular dystrophy, and liver cirrhosis.
=== Semen displacement === The shape of the human penis is thought to have evolved as a result of sperm competition. Semen displacement is an adaptation of the shape of the penis to draw foreign semen away from the cervix. This means that a male can displace a rival male's sperm from the female reproductive tract before replacing it with his own. Semen displacement has two main benefits for a male. Firstly, by displacing a rival male's sperm, the risk of the rival sperm fertilising the egg is reduced. Secondly, the male replaces the rival's sperm with his own, thereby increasing the probability of his fertilising the egg and successfully reproducing with the female. However, males have to ensure they do not displace their own sperm. It is thought that the relatively quick loss of erection after ejaculation, penile hypersensitivity following ejaculation, and the shallower, slower thrusting of the male after ejaculation prevent this from occurring. The coronal ridge is the part of the human penis thought to have evolved to allow for semen displacement. Research has studied how much semen is displaced by differently shaped artificial genitals. This research showed that, when combined with thrusting, the coronal ridge of the penis is able to remove the seminal fluid of a rival male from within the female reproductive tract. It does this by forcing the semen under the frenulum of the coronal ridge, causing it to collect behind the coronal ridge shaft.
14 October – David Lammy becomes the first UK Foreign Secretary to attend a meeting of EU foreign ministers since Brexit as part of Labour's wish to "reset" the UK's relationship with the EU. Monarchists in Australia have criticised a decision by the country's state premieres to be absent from a reception held by Charles III when he visits the country later in the month, describing it as a snub. 16 October – The Assisted Dying Bill is introduced into Parliament, criticised by Archbishop of Canterbury Justin Welby as "dangerous" and a "slippery slope". 17 October – Former Conservative MP Craig Mackinlay is formally introduced into the House of Lords as Lord Mackinlay of Richborough. Now affectionately known as the 'bionic lord', he is the first quadruple amputee to sit in the Lords. 2024 Conservative Party leadership election: Conservative Party leadership candidates Robert Jenrick and Kemi Badenoch take part in a leadership debate on GB News, but Badenoch has turned down an invitation to take part in a Question Time special on BBC One, and a planned online debate organised by The Sun. 18 October – King Charles III and Queen Camilla arrive in Australia for their royal tour, Charles's first visit to the country since becoming King. 10 Downing Street says there will be no apology for the UK's role in the transatlantic slave trade when Charles III and Starmer attend the Commonwealth summit in Samoa. Former Daily Record editor Murray Foote announces he is standing down as chief executive of the SNP after 14 months in the post.
== History == Brilliant Blue FCF was first synthesized in the early 20th century as part of the development of synthetic dyes derived from coal tar and aniline compounds. It gained regulatory prominence in the United States when it was among the first synthetic colorants certified for food use under the Federal Food, Drug, and Cosmetic Act of 1938. In 1969, following a safety review prompted by concerns over certain synthetic colorants, Brilliant Blue FCF was one of the few dyes permanently approved by the U.S. Food and Drug Administration for use in food, drugs, and cosmetics. Its vivid hue, water solubility, chemical stability, and low toxicity contributed to its widespread use. Despite ongoing interest in natural blue alternatives, Brilliant Blue FCF continues to be widely used in commercial products.
Sources: en.wikipedia.org
Fourteen isotopes of lawrencium are known, with mass number 251–262, 264, and 266; all are radioactive. Seven nuclear isomers are known. The longest-lived isotope, 266Lr, has a half-life of about ten hours and is one of the longest-lived superheavy isotopes known. However, shorter-lived isotopes are usually used in chemical experiments because 266Lr can only be produced as a final decay product of even heavier and harder-to-make elements: it was discovered in 2014 in the decay chain of 294Ts. 256Lr (half-life 27 seconds) was used in the first chemical studies on lawrencium: the longer-lived 260Lr (half-life 2.7 minutes) is usually used for this purpose. After 266Lr, the longest-lived isotopes are 264Lr (4.8+2.2−1.3 h), 262Lr (3.6 h), and 261Lr (44 min). All other known lawrencium isotopes have half-lives under 5 minutes, and the shortest-lived of them (251Lr) has a half-life of 24.4 milliseconds. The half-lives of lawrencium isotopes mostly increase smoothly from 251Lr to 266Lr, with a dip from 257Lr to 259Lr.
Flu-like symptoms Insomnia Nausea Imbalance Sensory disturbances, including "brain zaps" Hyperarousal A 2009 Advisory Committee to the U.S. Food and Drug Administration found that online anecdotal reports of discontinuation syndrome related to duloxetine included severe symptoms and exceeded prevalence of both paroxetine and venlafaxine reports by over 250% (although acknowledged this may have been influenced by duloxetine being a much newer drug). It also found that the safety information provided by the manufacturer not only neglected important information about managing discontinuation syndrome, but also explicitly advised against opening capsules, a practice required to gradually taper dosage.
== Actions == The Council announced a state of emergency in Port Sudan during tribal clashes which resulted in the death of 16 people on 26 August 2019. In November 2019, Abdalla Hamdok's government repealed all laws restricting women's freedom of dress, movement, association, work and study. On 22 April 2020, the transitional government issued an amendment to its criminal legislation which declares that anyone who performs female genital mutilation either in a medical establishment or elsewhere will be punished by three years' imprisonment and a fine.
=== Imaging === After determination using biomarkers, a variety of imaging studies may be used to differentiate between intrahepatic or extrahepatic cholestasis. Ultrasound is often used to identify the location of the obstruction but, is often insufficient in determining the level of biliary obstruction or its cause because it can pick up bowel gas that may interfere with readings. CT scans are not impacted by bowel gas and may also be more suitable for overweight patients. Typically, the cause of cholestasis and magnitude of obstruction is better diagnosed with CT compared to ultrasound. MRI scans provide similar information to CT scans but are more prone to interference from breathing or other bodily functions. Although CT, ultrasound, and MRI may help differentiate intrahepatic and extrahepatic cholestasis, the cause and extent of obstruction is best determined by cholangiography. Potential causes of extrahepatic cholestasis include obstructions outside the wall of the lumen, those outside the duct, and obstructions found in the duct lumen. Endoscopic retrograde cholangiography may be useful to visualize the extrahepatic biliary ducts. In case of anatomical anomalies, or if endoscopic retrograde cholangiography is unsuccessful, percutaneous transhepatic cholangiography may be used. CT or MRI-based cholangiography may also be useful, particularly in cases where additional interventions are not anticipated.
== Paleontology == Moscow has internationally significant paleontological monuments in its area. One of these is the Gorodnya River with its tributaries, on the banks of which are located outcrops of the Quaternary and older Cretaceous periods. Fossils of the bivalve mollusk Inoceramus kleinii and tubular passages of burrowing animals—described in 2017 as a new ichnospecies, Skolithos gorodnensis—were discovered in Coniacian deposits near the stream bed of the Bolshaya Glinka River. The trace fossils Ichnogenera Diplocraterion, Planolites, Skolithos, and possibly Ophiomorpha were found in Albian deposits. Paleolithic flint tools were discovered in the Quaternary deposits of the Bolshaya Glinka stream bed. In 1878, paleontologist Hermann Trautschold discovered the left flipper of an ichthyosaur (an extinct large marine reptile) near the village of Mnevniki, which later became part of Moscow. In 2014, this ichthyosaur was named Undorosaurus trautscholdi, after its discoverer. Trautschold determined the age of the sediments from which the specimen was taken to be Kimmeridgian; however, according to more recent studies, these sediments were formed during the Tithonian age of the Jurassic period. Other organisms—Albian foraminifera and ammonites—are also known from Moscow deposits. Fossils of various organisms are displayed in Moscow museums, including the Orlov Museum of Paleontology and the Vernadsky State Geological Museum.
Sources: en.wikipedia.org
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.
It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.
Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.